{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:32:28Z","timestamp":1773707548713,"version":"3.50.1"},"reference-count":53,"publisher":"Institute of Physiology of the Czech Academy of Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"published-print":{"date-parts":[[2024,11,29]]},"abstract":"<jats:p>Pulmonary arterial hypertension is characterized by perivascular and systemic inflammation. The gut microbiome influences the host immune system. Here we review the emerging preclinical and clinical evidence that strongly suggests that alterations in the gut microbiome may either initiate or facilitate progression of established pulmonary arterial hypertension by modifying the systemic immune responses. We also briefly review the relationship between the gut microbiome and preeclampsia, a vascular disease also characterized by inflammation.<\/jats:p>","DOI":"10.33549\/physiolres.935430","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T18:22:13Z","timestamp":1732299733000},"page":"S477-S485","source":"Crossref","is-referenced-by-count":4,"title":["Gut Microbiome and Pulmonary Arterial Hypertension \u2013 A Novel and Evolving Paradigm"],"prefix":"10.33549","author":[{"given":"T","family":"Thenappan","sequence":"first","affiliation":[{"name":"Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA. tthenapp@umn.edu"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EK","family":"Weir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"19169","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Thenappan T, Ormiston ML, Ryan JJ, Archer SL. Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ 2018;360:j5492. https:\/\/doi.org\/10.1136\/bmj.j5492","DOI":"10.1136\/bmj.j5492"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Chang KY, Duval S, Badesch DB, Bull TM, Chakinala MM, De Marco T, Frantz RP, Hemnes A, Mathai SC, Rosenzweig EB, Ryan JJ, Thenappan T, et al. Mortality in pulmonary arterial hypertension in the modern era: early insights from the pulmonary hypertension association registry. J Am Heart Assoc 2022;11:e024969. https:\/\/doi.org\/10.1164\/ajrccm-conference.2021.203.1_MeetingAbstracts.A1181","DOI":"10.1164\/ajrccm-conference.2021.203.1_meetingabstracts.a1181"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Anand V, Roy SS, Archer SL, Weir EK, Garg SK, Duval S, Thenappan T. Trends and outcomes of pulmonary arterial hypertension-related hospitalizations in the United States: Analysis of the nationwide inpatient sample database from 2001 through 2012. JAMA Cardiol 2016;1:1021-1029. https:\/\/doi.org\/10.1001\/jamacardio.2016.3591","DOI":"10.1001\/jamacardio.2016.3591"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, McLaughlin VV, Preston IR, Souza R, Waxman AB, Gr\u00fcnig E, Kope\u0107 G, Meyer G, Olsson KM, Rosenkranz S, Xu Y, Miller B, Fowler M, Butler J, Koglin J, de Oliveira Pena J, Humbert M, Investigators ST. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. N Engl J Med 2023;388:1478-1490. https:\/\/doi.org\/10.1056\/NEJMoa2213558","DOI":"10.1056\/nejmoa2213558"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Rabinovitch M, Guignabert C, Humbert M, Nicolls MR. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res 2014;115:165-175. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.301141","DOI":"10.1161\/circresaha.113.301141"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Thenappan T, Prins KW, Pritzker MR, Scandurra J, Volmers K, Weir EK. The critical role of pulmonary arterial compliance in pulmonary hypertension. Ann Am Thorac Soc 2016;13:276-284. https:\/\/doi.org\/10.1513\/AnnalsATS.201509-599FR","DOI":"10.1513\/annalsats.201509-599fr"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Thenappan T, Chan SY, Weir EK. Role of extracellular matrix in the pathogenesis of pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol 2018;315:H1322-H1331. https:\/\/doi.org\/10.1152\/ajpheart.00136.2018","DOI":"10.1152\/ajpheart.00136.2018"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Soon E, Holmes AM, Treacy CM, Doughty NJ, Southgate L, Machado RD, Trembath RC, Jennings S, Barker L, Nicklin P, Walker C, Budd DC, Pepke-Zaba J, Morrell NW. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 2010;122:920-927. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.933762","DOI":"10.1161\/circulationaha.109.933762"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Prins KW, Archer SL, Pritzker M, Rose L, Weir EK, Sharma A, Thenappan T. Interleukin-6 is independently associated with right ventricular function in pulmonary arterial hypertension. J Heart Lung Transplant 2018;37:376-384. https:\/\/doi.org\/10.1016\/j.healun.2017.08.011","DOI":"10.1016\/j.healun.2017.08.011"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Ormiston ML, Chang C, Long LL, Soon E, Jones D, Machado R, Treacy C, Toshner MR, Campbell K, et al. Impaired natural killer cell phenotype and function in idiopathic and heritable pulmonary arterial hypertension. Circulation 2012;126:1099-1109. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.110619","DOI":"10.1161\/circulationaha.112.110619"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Tamosiuniene R, Tian W, Dhillon G, Wang L, Sung YK, Gera L, Patterson AJ, Agrawal R, Rabinovitch M, et al. Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension. Circ Res 2011;109:867-879. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.236927","DOI":"10.1161\/circresaha.110.236927"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Singh RK, Chang HW, Yan D, Lee KM, Ucmak D, Wong K, Abrouk M, Farahnik B, Nakamura M, Zhu TH, Bhutani T, Liao W. Influence of diet on the gut microbiome and implications for human health. J Transl Med 2017;15:73. https:\/\/doi.org\/10.1186\/s12967-017-1175-y","DOI":"10.1186\/s12967-017-1175-y"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Liu Z, Liu HY, Zhou H, Zhan Q, Lai W, Zeng Q, Ren H, Xu D. Moderate-intensity exercise affects gut microbiome composition and influences cardiac function in myocardial infarction mice. Front Microbiol 2017;8:1687. https:\/\/doi.org\/10.3389\/fmicb.2017.01687","DOI":"10.3389\/fmicb.2017.01687"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Hall AB, Tolonen AC, Xavier RJ. Human genetic variation and the gut microbiome in disease. Nat Rev Genet 2017;18:690-699. https:\/\/doi.org\/10.1038\/nrg.2017.63","DOI":"10.1038\/nrg.2017.63"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Bretler T, Weisberg H, Koren O, Neuman H. The effects of antipsychotic medications on microbiome and weight gain in children and adolescents. BMC Med 2019;17:112. https:\/\/doi.org\/10.1186\/s12916-019-1346-1","DOI":"10.1186\/s12916-019-1346-1"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Cresci GA, Bawden E. Gut microbiome: What we do and don't know. Nutr Clin Pract 2015;30:734-746. https:\/\/doi.org\/10.1177\/0884533615609899","DOI":"10.1177\/0884533615609899"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. New England J Med 2016;375:2369-2379. https:\/\/doi.org\/10.1056\/NEJMra1600266","DOI":"10.1056\/nejmra1600266"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Mokkala K, Roytio H, Munukka E, Pietila S, Ekblad U, Ronnemaa T, Eerola E, Laiho A, Laitinen K. Gut microbiota richness and composition and dietary intake of overweight pregnant women are related to serum zonulin concentration, a marker for intestinal permeability. J Nutr 2016;146:1694-1700. https:\/\/doi.org\/10.3945\/jn.116.235358","DOI":"10.3945\/jn.116.235358"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Castro A, Bemer V, Nobrega A, Coutinho A, Truffa-Bachi P. Administration to mouse of endotoxin from gram-negative bacteria leads to activation and apoptosis of T lymphocytes. Eur J Immunol 1998;28:488-495. https:\/\/doi.org\/10.1002\/(SICI)1521-4141(199802)28:02<488::AID-IMMU488>3.0.CO;2-R","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<488::AID-IMMU488>3.0.CO;2-R"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. The role of short-chain fatty acids in health and disease. Adv Immunol 2014;121:91-119. https:\/\/doi.org\/10.1016\/B978-0-12-800100-4.00003-9","DOI":"10.1016\/b978-0-12-800100-4.00003-9"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Yuille S, Reichardt N, Panda S, Dunbar H, Mulder IE. Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid. PLoS One 2018;13:e0201073. https:\/\/doi.org\/10.1371\/journal.pone.0201073","DOI":"10.1371\/journal.pone.0201073"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Tan Y, Sheng Z, Zhou P, Liu C, Zhao H, Song L, Li J, Zhou J, Chen Y, Wang L, Qian H, Sun Z, Qiao S, Xu B, Gao R, Yan H. Plasma trimethylamine N-oxide as a novel biomarker for plaque rupture in patients with ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv 2019;12:e007281. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.118.007281","DOI":"10.1161\/circinterventions.118.007281"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Moutsoglou DM, Tatah J, Prisco SZ, Prins KW, Staley C, Lopez S, Blake M, Teigen L, Kazmirczak F, Weir EK, Kabage AJ, Guan W, Khoruts A, Thenappan T. Pulmonary Arterial hypertension patients have a proinflammatory gut microbiome and altered circulating microbial metabolites. Am J Respir Crit Care Med 2023;207:740-756. https:\/\/doi.org\/10.1164\/rccm.202203-0490OC","DOI":"10.1164\/rccm.202203-0490oc"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Kim S, Rigatto K, Gazzana MB, Knorst MM, Richards EM, Pepine CJ, Raizada MK. Altered gut microbiome profile in patients with pulmonary arterial hypertension. Hypertension 2020;75:1063-1071. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.14294","DOI":"10.1161\/hypertensionaha.119.14294"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Yang Y, Zeng Q, Gao J, Yang B, Zhou J, Li K, Li L, Wang A, Li X, Liu Z, Luo Q, Zhao Z, Liu B, Xue J, Jiang X, Konerman MC, Zheng L, Xiong C. High-circulating gut microbiota-dependent metabolite trimethylamine N-oxide is associated with poor prognosis in pulmonary arterial hypertension. Eur Heart J Open 2022;2:oeac021. https:\/\/doi.org\/10.1093\/ehjopen\/oeac021","DOI":"10.1093\/ehjopen\/oeac021"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Yang Y, Yang B, Li X, Xue L, Liu B, Liang Y, Zhao Z, Luo Q, Liu Z, Zeng Q, Xiong C. Higher circulating Trimethylamine N-oxide levels are associated with worse severity and prognosis in pulmonary hypertension: a cohort study. Respir Res 2022;23:344. https:\/\/doi.org\/10.1186\/s12931-022-02282-5","DOI":"10.1186\/s12931-022-02282-5"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Callejo M, Mondejar-Parreno G, Barreira B, Izquierdo-Garcia JL, Morales-Cano D, Esquivel-Ruiz S, Moreno L, Cogolludo A, Duarte J, Perez-Vizcaino F. Pulmonary arterial hypertension affects the rat gut microbiome. Sci Rep 2018;8:9681. https:\/\/doi.org\/10.1038\/s41598-018-27682-w","DOI":"10.1038\/s41598-018-27682-w"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Sanada TJ, Hosomi K, Shoji H, Park J, Naito A, Ikubo Y, Yanagisawa A, Kobayashi T, Miwa H, Suda R, Sakao S, Mizuguchi K, Kunisawa J, Tanabe N, Tatsumi K. Gut microbiota modification suppresses the development of pulmonary arterial hypertension in an SU5416\/hypoxia rat model. Pulm Circ 2020;10:2045894020929147. https:\/\/doi.org\/10.1177\/2045894020929147","DOI":"10.1177\/2045894020929147"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Karoor V, Strassheim D, Sullivan T, Verin A, Umapathy NS, Dempsey EC, Frank DN, Stenmark KR, Gerasimovskaya E. The short-chain fatty acid butyrate attenuates pulmonary vascular remodeling and inflammation in hypoxia-induced pulmonary hypertension. Int J Mol Sci 2021;22,9916. https:\/\/doi.org\/10.3390\/ijms22189916","DOI":"10.3390\/ijms22189916"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Huang Y, Lin F, Tang R, Bao C, Zhou Q, Ye K, Shen Y, Liu C, Hong C, Yang K, Tang H, Wang J, Lu W, Wang T. Gut Microbial Metabolite Trimethylamine. Am J Respir Cell Mol Biol 2022;66:452-460. https:\/\/doi.org\/10.1165\/rcmb.2021-0414OC","DOI":"10.1165\/rcmb.2021-0414oc"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Thenappan T, Goel A, Marsboom G, Fang YH, Toth PT, Zhang HJ, Kajimoto H, Hong Z, Paul J, Wietholt C, Pogoriler J, Piao L, Rehman J, Archer SL. A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion. Am J Respir Crit Care Med 2011;183:1080-1091. https:\/\/doi.org\/10.1164\/rccm.201008-1303OC","DOI":"10.1164\/rccm.201008-1303oc"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Ranchoux B, Bigorgne A, Hautefort A, Girerd B, Sitbon O, Montani D, Humbert M, Tcherakian C, Perros F. Gut-Lung Connection in Pulmonary Arterial Hypertension. Am J Respir Cell Mol Biol 2017;56:402-405. https:\/\/doi.org\/10.1165\/rcmb.2015-0404LE","DOI":"10.1165\/rcmb.2015-0404le"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Rabiller A, Nunes H, Lebrec D, Tazi KA, Wartski M, Dulmet E, Libert JM, Mougeot C, Moreau R, Mazmanian M, Humbert M, Herve P. Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am J Respir Crit Care Med 2002;166:514-517. https:\/\/doi.org\/10.1164\/rccm.200201-027OC","DOI":"10.1164\/rccm.200201-027oc"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Lin KY, Chen H, Yu L. Pulmonary arterial hypertension caused by congenital extrahepatic portocaval shunt: a case report. BMC Cardiovasc Disord 2019;19:141. https:\/\/doi.org\/10.1186\/s12872-019-1124-1","DOI":"10.1186\/s12872-019-1124-1"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Iida T, Ogura Y, Doi H, Yagi S, Kanazawa H, Imai H, Sakamoto S, Okamoto S, Uemoto S. Successful treatment of pulmonary hypertension secondary to congenital extrahepatic portocaval shunts (Abernethy type 2) by living donor liver transplantation after surgical shunt ligation. Transpl Int 2010;23:105-109. https:\/\/doi.org\/10.1111\/j.1432-2277.2009.00964.x","DOI":"10.1111\/j.1432-2277.2009.00964.x"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Tatah JH, Weir EK, Prins KW, Thenappan T. A case report of portopulmonary hypertension precipitated by transjugular intrahepatic portosystemic shunt. Chest 2021;159:e193-e196. https:\/\/doi.org\/10.1016\/j.chest.2020.11.014","DOI":"10.1016\/j.chest.2020.11.014"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Chesne J, Danger R, Botturi K, Reynaud-Gaubert M, Mussot S, Stern M, Danner-Boucher I, Mornex JF, Pison C, Dromer C, Kessler R, Dahan M, Brugiere O, Le Pavec J, Perros F, Humbert M, Gomez C, Brouard S, Magnan A, Consortium C. Systematic analysis of blood cell transcriptome in end-stage chronic respiratory diseases. PLoS One 2014;9:e109291. https:\/\/doi.org\/10.1371\/journal.pone.0109291","DOI":"10.1371\/journal.pone.0109291"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Morrell NW, Aldred MA, Chung WK, Elliott CG, Nichols WC, Soubrier F, Trembath RC, Loyd JE. Genetics and genomics of pulmonary arterial hypertension. Eur Respir J 2019;53, 1801899. https:\/\/doi.org\/10.1183\/13993003.01899-2018","DOI":"10.1183\/13993003.01899-2018"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Soon E, Crosby A, Southwood M, Yang P, Tajsic T, Toshner M, Appleby S, Shanahan CM, Bloch KD, Pepke-Zaba J, Upton P, Morrell NW. Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension. Am J Respir Crit Care Med 2015;192:859-872. https:\/\/doi.org\/10.1164\/rccm.201408-1509OC","DOI":"10.1164\/rccm.201408-1509oc"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Zhang C, Xi Y, Zhang Y, He P, Su X, Li Y, Zhang M, Liu H, Yu X, Shi Y. Causal effects between gut microbiota and pulmonary arterial hypertension: A bidirectional Mendelian randomization study. Heart Lung 2024;64:189-197. https:\/\/doi.org\/10.1016\/j.hrtlng.2024.01.002","DOI":"10.1016\/j.hrtlng.2024.01.002"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Huang Y, Lin F, Tang R, Bao C, Zhou Q, Ye K, Shen Y, Liu C, Hong C, Yang K, Tang H, Wang J, Lu W, Wang T. Gut microbial metabolite trimethylamine N-oxide aggravates pulmonary hypertension. Am J Respir Cell Mol Biol 2022. https:\/\/doi.org\/10.1165\/rcmb.2021-0414OC","DOI":"10.1165\/rcmb.2021-0414oc"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Prisco SZ, Eklund M, Moutsoglou DM, Prisco AR, Khoruts A, Weir EK, Thenappan T, Prins KW. Intermittent fasting enhances right ventricular function in preclinical pulmonary arterial hypertension. J Am Heart Assoc 2021;10:e022722. https:\/\/doi.org\/10.1161\/JAHA.121.022722","DOI":"10.1161\/jaha.121.022722"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Shaklee Sammons J, Sandora TJ, Wilcox MH. Clinical practice guidelines for clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018;66:e1-e48. https:\/\/doi.org\/10.1093\/cid\/cix1085","DOI":"10.1093\/cid\/cix1085"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Quagliariello A, Del Chierico F, Reddel S, Russo A, Onetti Muda A, D'Argenio P, Angelino G, Romeo EF, Dall'Oglio L, De Angelis P, Putignani L, All The Other Fmt Opbg Committee Collaborators. Fecal microbiota transplant in two ulcerative colitis pediatric cases: gut microbiota and clinical course correlations. Microorganisms 2020;8. https:\/\/doi.org\/10.3390\/microorganisms8101486","DOI":"10.3390\/microorganisms8101486"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Davar D, Dzutsev AK, McCulloch JA, Rodrigues RR, Chauvin JM, Morrison RM, Deblasio RN, et al. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Science 2021;371:595-602. https:\/\/doi.org\/10.1126\/science.abf3363","DOI":"10.1126\/science.abf3363"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Baruch EN, Youngster I, Ben-Betzalel G, Ortenberg R, Lahat A, Katz L, Adler K, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science 2021;371:602-609. https:\/\/doi.org\/10.1126\/science.abb5920","DOI":"10.1126\/science.abb5920"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Jama HA, Rhys-Jones D, Nakai M, Yao CK, Climie RE, Sata Y, Anderson D, et al. Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial. Nat Cardiovasc Res 2023;2:35-43. https:\/\/doi.org\/10.1038\/s44161-022-00197-4","DOI":"10.1038\/s44161-022-00197-4"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension 2008;52:873-880. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.108.117358","DOI":"10.1161\/hypertensionaha.108.117358"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res 2019;124:1094-1112. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313276","DOI":"10.1161\/circresaha.118.313276"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Kell DB, Kenny LC. A Dormant microbial component in the development of preeclampsia. Front Med (Lausanne) 2016;3:60. https:\/\/doi.org\/10.3389\/fmed.2016.00060","DOI":"10.3389\/fmed.2016.00060"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Liu J, Yang H, Yin Z, Jiang X, Zhong H, Qiu D, Zhu F, Li R. Remodeling of the gut microbiota and structural shifts in Preeclampsia patients in South China. Eur J Clin Microbiol Infect Dis 2017;36:713-719. https:\/\/doi.org\/10.1007\/s10096-016-2853-z","DOI":"10.1007\/s10096-016-2853-z"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Gomez-Arango LF, Barrett HL, McIntyre HD, Callaway LK, Morrison M, Dekker Nitert M, Group ST. Increased systolic and diastolic blood pressure is associated with altered gut microbiota composition and butyrate production in early pregnancy. Hypertension 2016;68: 974-981. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.116.07910","DOI":"10.1161\/hypertensionaha.116.07910"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Li P, Wang H, Guo L, Gou X, Chen G, Lin D, Fan D, Guo X, Liu Z. Association between gut microbiota and preeclampsia-eclampsia: a two-sample Mendelian randomization study. BMC Med 2022;20:443. https:\/\/doi.org\/10.1186\/s12916-022-02657-x","DOI":"10.1186\/s12916-022-02657-x"}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T18:22:18Z","timestamp":1732299738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biomed.cas.cz\/physiolres\/pdf\/2024\/73_S477.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":53,"URL":"https:\/\/doi.org\/10.33549\/physiolres.935430","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,22]]}}}